NIAID - National Institute of Allergy and Infectious Diseases
The Interventional Agents Safety and Pharmacokinetic Services (IASPS) program provides for preclinical/nonclinical services and activities required for the development of interventional products for infectious diseases including IND, NDA, or BLA for advanced products.
Up to $4K
2026-09-24
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
One-time $99 fee · Includes AI drafting + templates + PDF export
Role of Neutrophils in the Pathogenesis of Cholangiopathies
NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases — up to $3.2M
Vertically transferred antibodies protect babies from Escherichia coli infection
NIAID - National Institute of Allergy and Infectious Diseases — up to $2.8M
Molecular mechanism of metabolic stress in the pancreatic beta cells
NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases — up to $2.8M
Personalized Outreach and Multifaceted Interventions for Screening Enhancement (PROMISE) for Anal and Cervical Cancer Prevention and Treatment
NCI - National Cancer Institute — up to $2.3M
Response of the commensal microbiota to host physiological stress
NIGMS - National Institute of General Medical Sciences — up to $2.1M
Artificial Intelligence-based & Ethically-focused Multi-Modal Data Integration Framework for Screening, Diagnosing, and Caring for CKD Patients
OD - NIH Office of the Director — up to $2.1M